EGFR and neoplasm: These patients were initially stratified into six FISH groups according to an increasing number of copies of the EGFR gene in their tumor cells (disomy, low trisomy, high trisomy, low polysomy, high polysomy, and gene amplification) and these groups were evaluated for clinical outcome.